AVITA THERAPEUTICS, INC. (ASX:AVH)

Pharmaceuticals, Biotechnology & Life Sciences

AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.

AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.

FAQs

Does Avita pay a dividend?
No. Avita is an early stage medical company and as a result does not have a history of paying consistent dividends.
Where do I find my lost Avita shares?
Computershare is the Avita’s Share Registry provider, so if you have shares you may be able to log into Computershare’s website and find lost shares.
Does Avita offering a DRP?
No. Avita does not offer a dividend reinvestment plan because, as of 2020, it does not pay a dividend.